Vancomycin-resistant enterococci spread primarily through direct contact in healthcare settings, carried from patient to patient on the hands of healthcare workers and shared medical equipment. But that person-to-person chain is only part of the story. VRE also persists on environmental surfaces for weeks or months, colonizes the gut silently in people who show no symptoms, and can even pass its resistance genes to entirely different bacterial strains. Understanding the full picture of how VRE moves through hospitals, nursing facilities, and communities explains why it has been so stubbornly difficult to control since it first appeared in the late 1980s.
The Main Route Is Contact in Healthcare Facilities
The most well-documented path of VRE transmission is direct contact, and the most frequent vehicle is healthcare workers’ hands. A study tracking VRE transfer in real time found that after a healthcare worker touched a VRE-positive site and then touched a previously negative site, about one in ten of those clean sites became contaminated. Blood pressure cuffs and skin surfaces like the inner elbow were especially likely to pick up the organism during routine patient care.1PubMed. Transfer of vancomycin-resistant enterococci via health care worker hands That transfer rate might sound modest, but multiply it across dozens of patient contacts per shift, across an entire ward, and the math gets alarming quickly.
Shared medical equipment plays a supporting role. Stethoscopes, thermometers, bed rails, and IV poles can all serve as intermediaries. When a device touches a colonized patient and is not cleaned before being used on the next patient, VRE hitches a ride. The organism does not need an open wound or a compromised immune system to settle in; it simply needs to reach the gut, where it can quietly take up residence.
VRE Survives on Surfaces Far Longer Than You Might Expect
One reason contact transmission is so effective is that VRE is remarkably durable outside the body. In laboratory testing, VRE strains inoculated onto polyvinyl chloride surfaces survived for at least a week in every case, and some strains persisted for four full months under controlled conditions.2PubMed Central. Survival of vancomycin-resistant and vancomycin-susceptible enterococci on dry surfaces That kind of staying power means a contaminated bed rail, call button, or overbed table can remain a source of transmission long after the colonized patient has been discharged.
Environmental persistence also complicates cleaning. A genomic study of skilled nursing facilities found multiple cases in which VRE persisted in single rooms even after terminal cleaning with products that should have been effective against it. VRE showed a high degree of horizontal transmission among rooms within the same facility, suggesting that standard disinfection protocols sometimes fall short.3Journal of Hospital Infection. Genomic epidemiology and environmental persistence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in skilled nursing facilities This is not a failure of chemistry so much as a failure of coverage: organisms hiding in crevices, textured materials, or hard-to-reach corners of medical equipment can escape even a thorough wipe-down.
The Gut as a Silent Reservoir
Enterococci are natural inhabitants of the human intestinal tract. The genus name itself comes from “entero,” referring to the gut, and the two species that cause the most clinical trouble, E. faecalis and E. faecium, are the most abundant enterococcal species in human stool.4PubMed Central. Enterococci and Their Interactions with the Intestinal Microbiome When a vancomycin-resistant strain reaches the gut, it can settle in alongside the rest of the microbiome and remain there indefinitely without causing symptoms. This asymptomatic colonization is the norm, not the exception. Most people carrying VRE never develop an active infection.
The problem is that silently colonized patients shed VRE in their stool, contaminating their immediate environment and making them a persistent source of transmission. Genomic surveillance of hospitalized patients in Serbia confirmed that intestinal colonization serves as a critical reservoir for hospital-adapted VRE strains, reinforcing the need for screening even among patients who feel perfectly well.5PubMed. A genomic snapshot of hospital-adapted CC17 vancomycin-resistant Enterococcus faecium colonising high-risk patients in Serbia The colonized patient may never know they are carrying VRE, but the people around them, especially immunocompromised neighbors in the same ward, are at risk.
Antibiotics as Accelerants
The single most consistent risk factor for becoming colonized with VRE is antibiotic exposure, and vancomycin itself tops the list. A normal, diverse gut microbiome acts as a barrier against VRE because commensal bacteria compete for space and nutrients. When broad-spectrum antibiotics sweep through the gut, they clear out those protective communities and leave an ecological vacuum that resistant organisms rush to fill.4PubMed Central. Enterococci and Their Interactions with the Intestinal Microbiome
This pattern has been confirmed in multiple clinical settings. In a pediatric intensive care unit, vancomycin use was the only antibiotic significantly associated with VRE gut colonization.6PubMed Central. Risk factors for intestinal colonization with vancomycin resistant enterococci’ A prospective study in a level III pediatric intensive care unit Among hematology patients, vancomycin administration and altered bowel habits were the only independent risk factors that held up when other variables were accounted for, with vancomycin carrying roughly a threefold increase in the odds of colonization.7PubMed Central. Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study
The historical origin of VRE itself reflects this dynamic. VRE was first reported in 1986, about 30 years after vancomycin entered clinical use. Researchers believe a major inciting factor was the practice of giving vancomycin by mouth to treat antibiotic-associated diarrhea in hospitals, which bathed the gut in the exact selective pressure most likely to encourage vancomycin-resistant strains.8Emerging Infectious Diseases. Emergence of Vancomycin-Resistant Enterococci
Who Is Most Vulnerable
Not everyone in a hospital faces the same risk. VRE colonization and infection cluster heavily among patients with specific characteristics:
- Underlying illness: Diabetes, kidney failure, and cancer all increase susceptibility.
- Long hospital stays: The longer you are in the hospital, the more opportunities VRE has to reach you, especially if you are receiving broad-spectrum antibiotics like cephalosporins or vancomycin.
- Invasive devices: Central venous catheters, urinary catheters, and similar devices provide both a route of entry and a surface for bacterial attachment.
- Proximity to other carriers: Sharing a room or ward with a VRE-colonized patient is itself a documented risk factor.
These risk factors were identified in a comprehensive review of VRE epidemiology.9American Journal of Infection Control. Vancomycin-resistant enterococci: Epidemiology, infection control, and the molecular epidemiology of VRE bloodstream infection The practical upshot is that VRE spread concentrates in ICUs, oncology wards, transplant units, and long-term care facilities, the very places where patients are most medically fragile and least able to fight off an infection should one develop.
The C. difficile Connection
There is a notable overlap between VRE carriage and Clostridioides difficile infection. A study examining stool specimens submitted for C. difficile testing found that patients who tested positive for C. difficile toxin were significantly more likely to also harbor VRE: roughly 17% of C. difficile-positive specimens grew VRE, compared with about 6% of C. difficile-negative specimens.10PubMed Central. Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing
The connection makes biological sense. Both organisms thrive when the normal gut microbiome has been disrupted by antibiotics. Patients with active C. difficile infection also tend to have diarrhea, which increases shedding of VRE into the environment and amplifies the contamination of bed linens, toilets, and nearby surfaces. In infection-control terms, a patient with C. difficile-associated diarrhea and VRE colonization is a particularly efficient spreader, creating far more environmental contamination than someone who is colonized but has formed stool.
Spread Across Healthcare Networks
VRE does not respect the walls of a single hospital. Whole-genome sequencing of VRE strains from a healthcare network that included hospitals and long-term care facilities found that closely related strains circulated freely between the two settings. Residents of long-term care facilities and patients with hospital-acquired bloodstream infections shared VRE lineages scattered across the same branches of a phylogenetic tree, demonstrating that patients moving between facilities carry VRE with them.11PubMed Central. Whole-genome sequencing reveals transmission of vancomycin-resistant Enterococcus faecium in a healthcare network
This finding has practical implications for infection control. A hospital may keep its own VRE rates low, but if it regularly admits transfers from a long-term care facility with a VRE problem, the organism will keep arriving at the door. Effective control requires coordination across an entire regional healthcare network, not just within one institution.
How Resistance Genes Spread Between Bacteria
There is a second dimension to VRE transmission that goes beyond one bacterium physically traveling from one patient to another. The genes that encode vancomycin resistance sit on mobile genetic elements, meaning they can jump from one bacterial cell to another even without the original strain spreading. In Danish hospitals, researchers found that the dominant pattern was a resistance-carrying transposon and its associated plasmid spreading to multiple distinct populations of E. faecium through horizontal gene transfer. New VRE clones emerged when previously susceptible bacteria acquired these resistance elements and then expanded clonally.12Journal of Antimicrobial Chemotherapy. Genomic analysis of 495 vancomycin-resistant Enterococcus faecium reveals broad dissemination of a vanA plasmid in more than 19 clones from Copenhagen, Denmark
A separate Dutch study confirmed that in some hospital outbreak settings, the spread of resistance was driven mainly by this horizontal gene transfer rather than by the movement of a single resistant clone between patients.13PubMed Central. Mode and dynamics of vanA-type vancomycin resistance dissemination in Dutch hospitals In plain terms, VRE can “teach” its resistance trick to other enterococci already living in a patient’s gut. This means that even if you eliminate the original resistant strain, the resistance genes may have already been passed on, creating new VRE clones that sustain the problem.
Why VRE Spreads More Easily Than MRSA
VRE and MRSA are the two drug-resistant organisms that dominate infection-control discussions, but they do not behave identically. A transmission modeling study comparing the two found that VRE tended to have a higher transmission rate, a higher probability of being imported into a hospital, and a lower clearance rate. Together, these differences help explain why VRE colonization prevalence in hospitals is often higher than MRSA colonization prevalence.14Open Forum Infectious Diseases. A Dynamic Transmission Model to Evaluate the Effectiveness of Infection Control Strategies
The environmental persistence data lines up with this as well. Genomic surveillance in skilled nursing facilities documented that VRE showed a particularly high degree of room-to-room horizontal spread, more so than MRSA, even when both organisms were common in the same facility.3Journal of Hospital Infection. Genomic epidemiology and environmental persistence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in skilled nursing facilities If you are a hospital epidemiologist, VRE is in many ways the harder of the two to keep under control.
Infection Control Measures and Their Limits
The standard response to a VRE-positive patient is contact precautions: gowns and gloves for anyone entering the room, dedicated equipment, and enhanced cleaning. Logically this should work, and hand hygiene clearly matters given the hand-transfer data. But a systematic review and meta-analysis looking at contact precautions specifically found that they did not significantly reduce VRE acquisition rates on their own.15Journal of Antimicrobial Chemotherapy. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis That finding is sobering. It does not mean gowns and gloves are useless, but it suggests that in the real world, where compliance is imperfect and environmental contamination is persistent, contact precautions alone are insufficient.
The evidence points toward bundled strategies being more effective than any single measure. Combining hand hygiene enforcement, active surveillance screening to identify colonized patients early, antibiotic stewardship to reduce the selective pressure, and enhanced environmental cleaning gives each component a chance to catch what the others miss. Some facilities have also found success with dedicated nursing staff for VRE-positive patients, reducing the number of healthcare workers who move between colonized and uncolonized patients.
The question of active screening itself has generated debate. A Turkish hospital that stopped routine rectal screening found that VRE colonization rates rose afterward (from about 5% to roughly 10% in the adult hospital, and from about 6% to 12% in the oncology hospital), yet the rate of VRE bloodstream infections did not increase.16PubMed Central. Cessation of Rectal Screening for Vancomycin-Resistant Enterococci: Experience from a Tertiary Care Hospital from Türkiye That disconnect between colonization and clinical disease adds nuance: screening catches carriers, but whether finding those carriers translates into fewer serious infections depends on what you do with the information.
Environmental and Agricultural Reservoirs
VRE is not exclusively a hospital problem. The resistance genes, particularly the vanA and vanB operons, have been found in livestock, farm environments, and wastewater. The use of avoparcin, a glycopeptide antibiotic closely related to vancomycin, as a growth promoter in animal agriculture in Europe and elsewhere created a parallel selective pressure outside hospitals. This contributed to environmental and livestock reservoirs for the most common vancomycin-resistance genes, which show distinct genetic variability and apparently continued evolution across these settings.17PubMed Central. Vancomycin-Resistant Enterococci: A Review of Antimicrobial Resistance Mechanisms and Perspectives of Human and Animal Health
Europe banned avoparcin in 1997, and VRE prevalence in animals declined afterward in some countries. But the resistance genes did not disappear entirely. They continue to circulate in animal and environmental niches, and the concern is that these external reservoirs could periodically reintroduce resistance into hospital populations. The flow is not always one-directional, either: hospital wastewater can carry VRE into municipal sewage systems, potentially seeding community and environmental reservoirs.
Fecal Microbiota Transplantation as a Decolonization Strategy
Since VRE colonization of the gut is the engine that drives ongoing transmission, researchers have explored whether restoring a healthy gut microbiome could clear VRE from colonized patients. Fecal microbiota transplantation, which introduces stool from a healthy donor into a patient’s intestinal tract, has shown early promise. A systematic review found that among VRE patients receiving FMT, roughly half were decolonized within 12 months, compared with about one in eight in control groups.18PubMed Central. Faecal microbiota replacement to eradicate antimicrobial resistant bacteria in the intestinal tract – a systematic review
Another study reported that about two-thirds of patients who received FMT for multidrug-resistant organism colonization were decolonized within a year. Patients whose gut microbiome had higher richness and diversity before transplantation were more likely to clear VRE, suggesting that FMT works best when there is still some ecological foundation to build on.19PubMed. Fecal Microbiota Transplantation for multidrug-resistant organism: Efficacy and Response prediction These results are encouraging, though FMT for decolonization remains investigational. A broader review concluded that early evidence supports FMT’s potential to reduce antibiotic-resistant organism colonization by restoring microbial community composition, but further study is still needed.20PubMed Central. The Role of Fecal Microbiota Transplantation in Reducing Intestinal Colonization With Antibiotic-Resistant Organisms: The Current Landscape and Future Directions
If FMT or similar microbiome-restoration approaches eventually prove reliable enough for routine use, they could change the transmission equation fundamentally. Rather than just isolating colonized patients and hoping they eventually clear the organism on their own, clinicians could actively eliminate the gut reservoir that fuels ongoing spread. For now, antibiotic stewardship remains the most practical tool for limiting the gut disruption that lets VRE flourish in the first place.